Actinium225QualityChecker

Actinium225

decay correction endotoxins heavy metals impurities microbiology PET radionuclide purity radiopharma
Open selection

Actinium-225 Quality Checker — Actinium-225 for targeted alpha therapy (TAT)

ℹ️ Utility checks critical parameters of actinium-225:
• Specific activity (≥500 MBq/μmol for conjugates)
• Radiochemical purity (≥95%)
• Free actinium (≤5% for conjugates)
• Daughter nuclides: Fr-221, At-217, Bi-213, Tl-209
• pH, endotoxins, sterility, heavy metals

⚠️ CRITICAL: Free actinium >5% → bone/liver toxicity!
Daughter nuclides affect dosimetry and therapy efficacy!

Usage:
Actinium225QualityChecker.exe → demo mode (console output)
Actinium225QualityChecker.exe input.csv output.json → evaluate your data

Input format:
BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617

Supported product types:
• PSMA-617 — targeted alpha therapy for prostate cancer
• DOTATATE — targeted alpha therapy for neuroendocrine tumors
• FREEAC225 — unconjugated actinium-225 (for custom conjugation)

— WHY IS THIS NEEDED?
Actinium-225 — promising alpha-emitter for targeted alpha therapy (TAT):
• 10-day half-life — sufficient for synthesis and delivery
• 4 alpha particles in decay chain → high cytotoxicity
• Used in conjugates with PSMA-617, DOTATATE for metastatic cancer treatment
• Clinical trials show efficacy in resistant cancer forms

⚠️ CRITICAL:
• Specific activity ≥500 MBq/μmol — ensures sufficient dose for tumor cell destruction
• Free actinium ≤5% — UNBOUND actinium accumulates in bones and liver, causing toxicity!
• Daughter nuclides:
— Francium-221 (T½=4.8 min) — affects dosimetry
— Astatine-217 (T½=32 ms) — short-lived but critical for calculations
— Bismuth-213 (T½=46 min) — may detach from conjugate
— Thallium-209 (T½=2.2 min) — toxic to kidneys
• pH 4.0–7.0 — critical for blood compatibility during IV administration
• Endotoxins ≤175 EU/vial — critical for IV administration!
• Sterility — MANDATORY for all parenteral forms!

Key features:
• Support for different product types (conjugates and unconjugated actinium)
• Check of all 4 daughter nuclides in Ac-225 decay chain
• Specific limits for free actinium (≤5% for conjugates)
• Critical warnings about free actinium toxicity
• Automatic requirement determination based on product type

Critical parameters:
• Specific activity: ≥500 MBq/μmol (conjugates), ≥1000 MBq/μmol (unconjugated)
• Radiochemical purity: ≥95.0%
• Free actinium: ≤5.0% (conjugates), N/A (unconjugated)
• Francium-221: ≤2.0%
• Astatine-217: ≤1.0%
• Bismuth-213: ≤3.0%
• Thallium-209: ≤1.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. For conjugates (PSMA-617, DOTATATE) free actinium control is critical
2. For unconjugated Ac-225 focus on specific activity and daughter nuclides
3. Daughter nuclides measured by alpha spectrometry
4. Free actinium controlled by TLC or HPLC
5. All measurements should be performed within 24 hours after synthesis

⚠️ Note: Actinium-225 is a NEW class of agents for targeted alpha therapy. Quality requirements are stricter than for beta-emitters due to high cytotoxicity of alpha particles. Even minor impurities can lead to serious side effects.

input.csv

BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: Actinium225QualityCheckerAPI / object: Actinium225Category: Radiopharmaceuticals

1. Scope

The Actinium225 Quality Checker utility is used for Actinium225. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Radiopharmaceuticals

Tags: decay correction, endotoxins, heavy metals, impurities, microbiology, PET, radionuclide purity, radiopharma, SPECT, sterility

2. Execution modes

Actinium225QualityChecker.exe                            → demo mode (console output)
Actinium225QualityChecker.exe input.csv output.json      → evaluate your data

3. Key controlled areas

  • purity and impurities
  • microbiology and pathogens
  • heavy metals / elemental impurities
  • pH and physicochemical parameters
  • activity, decay and radiochemical purity

4. Domain limits and critical parameters

  • ℹ️ Utility checks critical parameters of actinium-225:
  • Specific activity (≥500 MBq/μmol for conjugates)
  • Radiochemical purity (≥95%)
  • Free actinium (≤5% for conjugates)
  • Daughter nuclides: Fr-221, At-217, Bi-213, Tl-209
  • pH, endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Free actinium >5% → bone/liver toxicity!
  • ⚠️ CRITICAL:
  • Specific activity ≥500 MBq/μmol — ensures sufficient dose for tumor cell destruction
  • Free actinium ≤5% — UNBOUND actinium accumulates in bones and liver, causing toxicity!
  • Daughter nuclides:
  • — Francium-221 (T½=4.8 min) — affects dosimetry
  • — Astatine-217 (T½=32 ms) — short-lived but critical for calculations
  • — Bismuth-213 (T½=46 min) — may detach from conjugate
  • — Thallium-209 (T½=2.2 min) — toxic to kidneys
  • pH 4.0–7.0 — critical for blood compatibility during IV administration
  • Endotoxins ≤175 EU/vial — critical for IV administration!
  • Sterility — MANDATORY for all parenteral forms!
  • Support for different product types (conjugates and unconjugated actinium)
  • Check of all 4 daughter nuclides in Ac-225 decay chain
  • Specific limits for free actinium (≤5% for conjugates)
  • Critical warnings about free actinium toxicity
  • Automatic requirement determination based on product type
  • Critical parameters:
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Actinium225 with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: purity and impurities, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters, activity, decay and radiochemical purity.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberAC225-PSMA-2026-001mandatory field; used for batch/lot traceability
2SpecificActivityMBqPerUmoldecimalMBqSpecific Activity MBq per Umol600.0mandatory numeric value; rule comparison is performed by the utility
3RadiochemicalPurityPercentdecimal%Radiochemical Purity %97.0numeric value; compared with assay/purity limit from specification or method
4FreeActiniumPercentdecimal%Free Actinium %3.0mandatory numeric value; rule comparison is performed by the utility
5Francium221ImpurityPercentdecimal%Francium221 Impurity %1.5numeric value; compared with individual or total impurity limit
6Astatine217ImpurityPercentdecimal%Astatine217 Impurity %0.5numeric value; compared with individual or total impurity limit
7Bismuth213ImpurityPercentdecimal%Bismuth213 Impurity %2.0numeric value; compared with individual or total impurity limit
8Thallium209ImpurityPercentdecimal%Thallium209 Impurity %0.8numeric value; compared with individual or total impurity limit
9pHdecimalpHp H5.5mandatory numeric value; rule comparison is performed by the utility
10EndotoxinsEUdecimalas specifiedEndotoxins EU100.0numeric value; critical safety attribute compared with endotoxin limit
11SterilityTestboolean / flag0/1Sterility Test0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
12HeavyMetalsPPMdecimalppmHeavy Metals PPM5numeric value; checked as elemental/metal impurity
13ProductTypetextas specifiedProduct TypePSMA-617mandatory value; format and acceptability are checked by the utility

CSV example

BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable Actinium225QualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Actinium225, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "Actinium225QualityChecker",
  "api": "Actinium225",
  "batchNumber": "AC225-PSMA-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "AC225-PSMA-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityMBqPerUmol",
      "value": "600.0",
      "unit": "MBq",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "97.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeActiniumPercent",
      "value": "3.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Francium221ImpurityPercent",
      "value": "1.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Astatine217ImpurityPercent",
      "value": "0.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Bismuth213ImpurityPercent",
      "value": "2.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Thallium209ImpurityPercent",
      "value": "0.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-008Incorrect activity, reference time or radiochemical purityFAIL/WARNING is produced with calculation traceability.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Andrology QC Suite

QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.

Open

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Gastroenterology QC Suite

QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad QC Suite

A specialised utility package for radiopharmaceutical quality control: PET, SPECT, therapeutic radionuclides, generators and decay calculations.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: alpha-emitting therapy

Ac-225, Ra-223, At-211, Bi-213 and Th-227: targeted alpha therapy and daughter/recoil control.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH use case: radionuclide therapy and theranostics

Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.

Open

RPH workflow: dosimetry and therapy planning

Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open

Urology QC Suite

QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.

Open